KAYS
Price
$0.01
Change
-$0.01 (-50.00%)
Updated
Aug 15 closing price
Capitalization
469.68K
SHIEF
Price
$0.04
Change
+$0.01 (+33.33%)
Updated
Jun 27 closing price
Capitalization
78.53M
Interact to see
Advertisement

KAYS vs SHIEF

Header iconKAYS vs SHIEF Comparison
Open Charts KAYS vs SHIEFBanner chart's image
Kaya Holdings
Price$0.01
Change-$0.01 (-50.00%)
Volume$3.17K
Capitalization469.68K
Shield Therapeutics
Price$0.04
Change+$0.01 (+33.33%)
Volume$10K
Capitalization78.53M
KAYS vs SHIEF Comparison Chart in %
Loading...
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KAYS vs. SHIEF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KAYS is a StrongBuy and SHIEF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (KAYS: $0.01 vs. SHIEF: $0.04)
Brand notoriety: KAYS and SHIEF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: KAYS: 13% vs. SHIEF: 103%
Market capitalization -- KAYS: $469.68K vs. SHIEF: $78.53M
KAYS [@Pharmaceuticals: Generic] is valued at $469.68K. SHIEF’s [@Pharmaceuticals: Generic] market capitalization is $78.53M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KAYS’s FA Score shows that 1 FA rating(s) are green whileSHIEF’s FA Score has 0 green FA rating(s).

  • KAYS’s FA Score: 1 green, 4 red.
  • SHIEF’s FA Score: 0 green, 5 red.
According to our system of comparison, KAYS is a better buy in the long-term than SHIEF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KAYS’s TA Score shows that 5 TA indicator(s) are bullish while SHIEF’s TA Score has 3 bullish TA indicator(s).

  • KAYS’s TA Score: 5 bullish, 4 bearish.
  • SHIEF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, both KAYS and SHIEF are a good buy in the short-term.

Price Growth

KAYS (@Pharmaceuticals: Generic) experienced а -1.74% price change this week, while SHIEF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SHIEF($78.5M) has a higher market cap than KAYS($470K). SHIEF YTD gains are higher at: 11.594 vs. KAYS (-59.643).
KAYSSHIEFKAYS / SHIEF
Capitalization470K78.5M1%
EBITDA-1.68MN/A-
Gain YTD-59.64311.594-514%
P/E Ratio3.30N/A-
Revenue14.2KN/A-
Total Cash50.7KN/A-
Total Debt9.17MN/A-
FUNDAMENTALS RATINGS
KAYS vs SHIEF: Fundamental Ratings
KAYS
SHIEF
OUTLOOK RATING
1..100
5439
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
90
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9744
P/E GROWTH RATING
1..100
194
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KAYS's Valuation (52) in the null industry is somewhat better than the same rating for SHIEF (90). This means that KAYS’s stock grew somewhat faster than SHIEF’s over the last 12 months.

KAYS's Profit vs Risk Rating (100) in the null industry is in the same range as SHIEF (100). This means that KAYS’s stock grew similarly to SHIEF’s over the last 12 months.

SHIEF's SMR Rating (97) in the null industry is in the same range as KAYS (100). This means that SHIEF’s stock grew similarly to KAYS’s over the last 12 months.

SHIEF's Price Growth Rating (44) in the null industry is somewhat better than the same rating for KAYS (97). This means that SHIEF’s stock grew somewhat faster than KAYS’s over the last 12 months.

KAYS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for SHIEF (94). This means that KAYS’s stock grew significantly faster than SHIEF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KAYSSHIEF
RSI
ODDS (%)
Bullish Trend 3 days ago
56%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 4 days ago
27%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
46%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
33%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
31%
Advances
ODDS (%)
Bullish Trend 5 days ago
68%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
77%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
10%
View a ticker or compare two or three
Interact to see
Advertisement
KAYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHIEF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PSNYW0.16N/A
+2.96%
Polestar Automotive Holding UK PLC
IBG0.63-0.01
-1.17%
Innovation Beverage Group Ltd
NOTE0.52-0.02
-3.01%
FiscalNote Holdings
JOBY16.63-0.74
-4.26%
Joby Aviation
NXTT1.14-0.13
-10.24%
Next Technology Holding

KAYS and

Correlation & Price change

A.I.dvisor tells us that KAYS and KMDA have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KAYS and KMDA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KAYS
1D Price
Change %
KAYS100%
-29.38%
KMDA - KAYS
20%
Poorly correlated
+0.68%
UPC - KAYS
5%
Poorly correlated
-1.12%
VRNOF - KAYS
3%
Poorly correlated
-19.33%
KKPCF - KAYS
2%
Poorly correlated
N/A
SHIEF - KAYS
2%
Poorly correlated
N/A
More

SHIEF and

Correlation & Price change

A.I.dvisor tells us that SHIEF and ORGO have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHIEF and ORGO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHIEF
1D Price
Change %
SHIEF100%
N/A
ORGO - SHIEF
22%
Poorly correlated
+0.64%
VRNOF - SHIEF
14%
Poorly correlated
-19.33%
AAWH - SHIEF
11%
Poorly correlated
+1.72%
HYEX - SHIEF
3%
Poorly correlated
N/A
KAYS - SHIEF
2%
Poorly correlated
-29.38%
More